VanEck Biotech ETF Rating $164.98 -0.14 (-0.08%) Closing price 07/25/2025 03:58 PM EasternExtended Trading$164.96 -0.02 (-0.02%) As of 07/25/2025 04:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock VanEck Biotech ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BBH Aggregate RatingModerate Buy 2.66Holdings in BBH have an aggregate rating of Moderate Buy based on 489 analyst ratings issued in the past year covering 24 companies (100.0% of the portfolio).BBH Aggregate Price Target$164.98High Prediction$164.98Average Prediction$164.98Low Prediction$164.98Holdings in BBH have an aggregate price target of $164.98 and a range of $164.98 to $164.98 covering 24 companies (100.0% of the portfolio).BBH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy4 Buy rating(s)Moderate Buy12 Moderate Buy rating(s)Hold8 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by VanEck Biotech ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 24 BBH Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings15.81%AMGNAmgen$306.58-0.6%4.4062 of 5 stars2.35$307.27 0.2%23Positive NewsAnalyst Forecast12.99%GILDGilead Sciences$116.20+2.7%4.8879 of 5 stars2.81$112.36 -3.3%26Trending NewsAnalyst Upgrade10.58%VRTXVertex Pharmaceuticals$469.65-0.6%4.3226 of 5 stars2.52$512.30 9.1%27Positive NewsAnalyst Revision5.09%REGNRegeneron Pharmaceuticals$563.10-0.3%4.8268 of 5 stars2.75$828.86 47.2%24Trending NewsUpcoming EarningsAnalyst Forecast4.93%ARGXargenex$591.99+0.0%3.6719 of 5 stars3.10$728.06 23.0%21Trending NewsUpcoming EarningsAnalyst Revision4.86%ALNYAlnylam Pharmaceuticals$328.81+0.2%4.0702 of 5 stars2.81$347.75 5.8%26News CoveragePositive NewsUpcoming Earnings4.60%NTRANatera$138.90-1.5%2.5863 of 5 stars3.00$184.63 32.9%15Trending NewsInsider TradeAnalyst Revision4.54%IQVIQVIA$199.17-0.8%4.5674 of 5 stars2.79$228.62 14.8%24Trending NewsEarnings ReportAnalyst ForecastInsider TradeAnalyst Revision3.70%INSMInsmed$103.95+0.4%3.9267 of 5 stars3.00$109.20 5.1%17News CoverageAnalyst ForecastInsider Trade3.48%BIIBBiogen$131.52-0.8%4.8086 of 5 stars2.34$186.37 41.7%32Upcoming EarningsAnalyst Revision3.24%ICLRIcon$187.01-4.1%4.0687 of 5 stars2.81$219.54 17.4%16Trending NewsEarnings ReportAnalyst Upgrade2.97%BNTXBioNTech$115.31+0.6%1.4352 of 5 stars2.83$136.58 18.4%18News Coverage2.97%ILMNIllumina$109.30+1.5%4.6269 of 5 stars2.40$125.11 14.5%20News CoverageUpcoming Earnings2.88%NBIXNeurocrine Biosciences$132.14+0.4%4.4413 of 5 stars2.88$163.87 24.0%24Upcoming EarningsAnalyst Forecast2.86%ONCBeOne Medicines$291.47-1.7%1.2901 of 5 stars3.00$327.56 12.4%7Analyst UpgradeInsider Trade2.35%MRNAModerna$34.15+0.4%4.2995 of 5 stars2.04$46.11 35.0%25Upcoming EarningsAnalyst Forecast2.15%INCYIncyte$70.20-0.4%4.6277 of 5 stars2.22$74.47 6.1%18Positive NewsUpcoming EarningsInsider Trade1.83%TECHBio-Techne$58.78+0.5%4.6739 of 5 stars2.62$69.58 18.4%13Analyst Upgrade1.74%QGENQiagen$51.80+1.1%3.5861 of 5 stars2.30$49.40 -4.6%10Analyst DowngradeAnalyst Revision1.62%CRLCharles River Laboratories International$176.85-0.1%4.4603 of 5 stars2.25$174.54 -1.3%16Positive News1.54%EXASExact Sciences$48.49-0.6%4.7406 of 5 stars2.95$70.50 45.4%22News CoveragePositive News1.51%BMRNBioMarin Pharmaceutical$59.01-1.3%4.9857 of 5 stars2.75$93.74 58.9%24Analyst Forecast1.39%RGENRepligen$121.74-0.1%4.6397 of 5 stars2.69$169.92 39.6%13Upcoming EarningsAnalyst Forecast0.36%SRPTSarepta Therapeutics$11.93-7.4%4.6939 of 5 stars2.11$51.42 331.0%28Trending NewsAnalyst DowngradeGap Down This page (NASDAQ:BBH) was last updated on 7/26/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump's 2025 Economic Revolution Is Here Are Your Retirement Savings Ready?Time is short. Trump's reforms may be coming fast—and the financial system roller coaster may be a ride that y...Create New Advertiser | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Biotech ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share VanEck Biotech ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
